Communications Biology (Aug 2022)

Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease

  • Vasundara Srinivasan,
  • Hévila Brognaro,
  • Prince R. Prabhu,
  • Edmarcia Elisa de Souza,
  • Sebastian Günther,
  • Patrick Y. A. Reinke,
  • Thomas J. Lane,
  • Helen Ginn,
  • Huijong Han,
  • Wiebke Ewert,
  • Janina Sprenger,
  • Faisal H. M. Koua,
  • Sven Falke,
  • Nadine Werner,
  • Hina Andaleeb,
  • Najeeb Ullah,
  • Bruno Alves Franca,
  • Mengying Wang,
  • Angélica Luana C. Barra,
  • Markus Perbandt,
  • Martin Schwinzer,
  • Christina Schmidt,
  • Lea Brings,
  • Kristina Lorenzen,
  • Robin Schubert,
  • Rafael Rahal Guaragna Machado,
  • Erika Donizette Candido,
  • Danielle Bruna Leal Oliveira,
  • Edison Luiz Durigon,
  • Stephan Niebling,
  • Angelica Struve Garcia,
  • Oleksandr Yefanov,
  • Julia Lieske,
  • Luca Gelisio,
  • Martin Domaracky,
  • Philipp Middendorf,
  • Michael Groessler,
  • Fabian Trost,
  • Marina Galchenkova,
  • Aida Rahmani Mashhour,
  • Sofiane Saouane,
  • Johanna Hakanpää,
  • Markus Wolf,
  • Maria Garcia Alai,
  • Dusan Turk,
  • Arwen R. Pearson,
  • Henry N. Chapman,
  • Winfried Hinrichs,
  • Carsten Wrenger,
  • Alke Meents,
  • Christian Betzel

DOI
https://doi.org/10.1038/s42003-022-03737-7
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 12

Abstract

Read online

Three natural phenolic compounds are found to bind to an allosteric site in SARS-CoV-2 papain-like protease and exhibit antiviral activity in vitro, showing potential as starting scaffolds for drug design.